Search by Drug Name or NDC
NDC 00115-1911-01 Rimantadine Hydrochloride 100 mg/1 Details
Rimantadine Hydrochloride 100 mg/1
Rimantadine Hydrochloride is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals of New York LLC. The primary component is RIMANTADINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Rimantadine is used to prevent and treat infections caused by influenza A virus. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 00115-1911-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Rimantadine
Product Information
| NDC | 00115-1911 |
|---|---|
| Product ID | 0115-1911_b5f5cd6c-3874-4507-bbd4-72e8c5bfe17f |
| Associated GPIs | 12500070100320 |
| GCN Sequence Number | 020987 |
| GCN Sequence Number Description | rimantadine HCl TABLET 100 MG ORAL |
| HIC3 | W5A |
| HIC3 Description | ANTIVIRALS, GENERAL |
| GCN | 00730 |
| HICL Sequence Number | 008646 |
| HICL Sequence Number Description | RIMANTADINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Rimantadine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Rimantadine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/1 |
| Substance Name | RIMANTADINE HYDROCHLORIDE |
| Labeler Name | Amneal Pharmaceuticals of New York LLC |
| Pharmaceutical Class | Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA076132 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00115-1911-01 (00115191101)
| NDC Package Code | 0115-1911-01 |
|---|---|
| Billing NDC | 00115191101 |
| Package | 100 TABLET, FILM COATED in 1 BOTTLE (0115-1911-01) |
| Marketing Start Date | 2021-11-16 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |